Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Concomitant Chemoradiotherapy With 776C85, 5-FU and Hydroxyurea for Patients With Poor Prognosis Oral Cancer

NCT00004901 is registered in ClinicalTrials.gov with Robert H. Lurie Cancer Center as lead sponsor.

NCT NCT00004901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Concomitant Chemoradiotherapy With 776C85, 5-FU and Hydroxyurea for Patients With Poor Prognosis Oral Cancer
Lead sponsor
Robert H. Lurie Cancer Center
Phase
Phase 1/2
Overall status
Completed
Start date
October 31, 1999
Completion date
July 31, 2004
Enrollment
Not reported
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer